ADRIAN ZHUBI: Open Payments
NPI 1861634990 · NAPERVILLE, IL. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$979 in 46 payments from 15 companies in 2025. Trend: 2023 $567 · 2024 $544 · 2025 $979
Food & beverage: $979
| Company | Payments | Amount |
|---|---|---|
| ABBVIE INC. | 11 | $237 |
| E.R. Squibb & Sons, L.L.C. | 8 | $182 |
| Janssen Pharmaceuticals, Inc | 5 | $111 |
| Vanda Pharmaceuticals Inc. | 2 | $66 |
| Lundbeck LLC | 3 | $56 |
| Otsuka America Pharmaceutical, Inc. | 3 | $55 |
| Indivior Inc. | 2 | $47 |
| Alkermes, Inc. | 2 | $40 |
| Tris Pharma Inc | 2 | $38 |
| ITI, Inc. (d/b/a Intra-Cellular Therapies, Inc.) | 2 | $34 |
Products named: VRAYLAR, COBENFY, REXULTI, FANAPT, SPRAVATO, INVEGA SUSTENNA, SUBLOCADE, Dyanavel XR.
Industry payments across IL — which companies pay providers there.
